Abstract：【Objective】 To investigate the relationship between the changes of serum growth differentiation factor-15 (GDF-15) and lipoprotein associated phospholipase A2 (Lp-PLA2) and cardiac function and ventricular remodeling in patients with chronic heart failure (CHF). 【Methods】 A total of 140 patients with CHF Treated in Wuxi People's Hospital from January 2017 to March 2019 (observation group) and 70 healthy volunteers in the same period (control group). The levels of serum GDF-15, Lp-PLA2, N-terminal pro brain natriuretic peptide (NT-proBNP) and cardiac function indexes [left ventricular ejection fraction (LVEF%), left ventricular short axis shortening (FS%) and left ventricular mass index (LVMI)] were compared between the two groups, and their correlation was analyzed.【Results】The levels of serum GDF-15, Lp-PLA2 and NT-proBNP in the observation group were significantly higher than those in the control group (P<0.05). The level of LVMI in the observation group was significantly higher than that in the control group, and the levels of LVEF and FS were significantly lower than that in the control group (P<0.05). The levels of serum GDF-15 and Lp-PLA2 in CHF patients with NYHA grade Ⅱ, Ⅲ and Ⅳ increased gradually, and there were significant differences between the groups (mean P<0.05). The levels of serum GDF-15 and Lp-PLA2 in CHF were significantly negatively correlated with LVEF and FS (P<0.05), and positively correlated with LVMI and serum NT-proBNP (P<0.05). 【Conclusion】 The levels of serum GDF-15 and Lp-PLA2 in patients with CHF are significantly increased, which are closely related to cardiac function and ventricular remodeling.
葛振忠, 宫照伟, 宁益, 郭殿龙. CHF患者血清GDF-15、Lp-PLA2变化与心功能、心室重构的相关性分析[J]. 医学临床研究, 2021, 38(10): 1544-1546.
GE Zhen-zhong, GONG Zhao-wei, NING Yi, et al. Correlation between Changes of Serum GDF-15, Lp-PLA2 and Cardiac Function and Ventricular Remodeling in Patients with CHF. JOURNAL OF CLINICAL RESEARCH, 2021, 38(10): 1544-1546.
2021, Vol. 38 
